These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 400006)

  • 1. [Controlled clinical study of the therapeutic activity of arginine thiazolidine carboxylate in patients with chronic toxic and postinfective hepatopathies].
    Salsano F; Ciancarelli MP
    Minerva Dietol Gastroenterol; 1979; 25(4):391-8. PubMed ID: 400006
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapeutic action of arginine-thiazolidine-carboxylate (ATCA) as evaluated by liver function tests].
    Alvisĭ V; D'Ambrosi A; Lo Ponte A; Tampieri ML; Tralli M
    Arch Sci Med (Torino); 1980; 137(4):731-8. PubMed ID: 7018458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical trial with arginine tidiacicate in symptomatic chronic persistent hepatitis.
    Rizzo S
    Int J Clin Pharmacol Res; 1986; 6(3):225-30. PubMed ID: 3527997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Normalizing effect of arginine thiazolidincarboxylate (ATCA) on hepatocytes in CCL4 poisoning in rats].
    Marcucci A; Ferrario F; Carminati R; Falchi M; Dubini F
    Farmaco Prat; 1980 Jun; 35(6):286-93. PubMed ID: 7449949
    [No Abstract]   [Full Text] [Related]  

  • 5. [Transmethylating activity of arginine thiazolidinecarboxylate (ATCA) in acute CCL4 poisoning and diet-induced steatosis in the rat].
    Ferrario F; Marcucci A; Bortolan-Gianese P; Falchi M; Dubini F
    Farmaco Prat; 1980 Jun; 35(6):294-307. PubMed ID: 7449950
    [No Abstract]   [Full Text] [Related]  

  • 6. [Use of arginine thiazolidine carboxylate in the treatment of chronic hepatitis. Preliminary findings].
    Bramato C; Salassa B; Soranzo ML; Bosio G; Andreoni G
    Minerva Dietol Gastroenterol; 1982; 28(1):65-70. PubMed ID: 7043311
    [No Abstract]   [Full Text] [Related]  

  • 7. [Value of the use of a new hepatotropic drug, arginine tidiacicate in gastroenterology. Results of a multicentric study].
    Raymond N
    Med Chir Dig; 1981; 10(2):181-4. PubMed ID: 7230954
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapeutic effectiveness of thiazolidinecarboxylate of arginine in psychiatric patients with hepatic disorders of toxic origin (alcohol, drugs)].
    Trasatti GA; Ripani G
    Clin Ter; 1979 Nov; 91(4):395-405. PubMed ID: 540484
    [No Abstract]   [Full Text] [Related]  

  • 9. [Thiazolidine-carboxylic acid in the ambulatory treatment of chronic hepatopathies].
    Russu G; Lungu I; Boingeanu A
    Rev Med Chir Soc Med Nat Iasi; 1974; 78(3):585-90. PubMed ID: 4453681
    [No Abstract]   [Full Text] [Related]  

  • 10. Arginine thiazolidinecarboxylate in the treatment of chronic active hepatitis: double-blind comparison with placebo.
    Miracco A; Iodice G; Peluso C; Quarentelli A; Selce P; Tedesco A; Pastore P
    J Int Med Res; 1984; 12(1):35-9. PubMed ID: 6363155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Controlled clinical trial in the treatment of chronic hepatopathy of toxico-metabolic etiology].
    Carrara G; Fiocchi G; Sotti A; Dieci MG; Fiorani F; Galvani V
    Clin Ter; 1984 Jun; 109(6):545-55. PubMed ID: 6236945
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hepatoprotective drugs. Clinical results of the use of a sulfhydryl-methylating preparation].
    Rapino P; Marulli R; Rapex G; Della Lunga S; Sabatino P
    Minerva Med; 1982 Oct; 73(40):2853-60. PubMed ID: 7133498
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effects of administration of arginine thiazolidinecarboxylate in liver pathology of various origins. Results of a multicenter study].
    Gasbarrini G; Bernardi M
    Minerva Dietol Gastroenterol; 1982; 28(2):143-52. PubMed ID: 7099448
    [No Abstract]   [Full Text] [Related]  

  • 14. [The control of bronchial secretions in chronic hypersecretory bronchopneumopathies: the role of letosteine].
    Morandini G; Finiguerra M; Fraticelli G; Ferraris F; Gallone F
    Clin Ter; 1986 Feb; 116(3):179-93. PubMed ID: 3516541
    [No Abstract]   [Full Text] [Related]  

  • 15. [Antihepatotoxic activity of arginine thiazolidinecarboxylate in hepatitis induced by galactosamine in the rat].
    Carminati R; Falchi M; Nebuloni R; Guadagni L; Lodi R
    Farmaco Prat; 1979 Apr; 34(4):163-7. PubMed ID: 456554
    [No Abstract]   [Full Text] [Related]  

  • 16. [Further clinical observations on the treatment of noncirrhotic alcoholic liver disease].
    Buzzi S; Ghetti C; Sala G
    Ateneo Parmense Acta Biomed; 1980; 51(3):139-45. PubMed ID: 7213456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic effects of tiopronin on chronic hepatitis: a double-blind clinical study.
    Ichida F; Shibasaki K; Takino T; Suzuki H; Fujisawa K; Inoue K; Hirayama C; Kaito I; Hirasawa T; Kameda H; Inoue J; Satoh G; Kosaka Y; Yamamoto S; Nagashima H; Tsuji T; Ohta Y; Okada J
    J Int Med Res; 1982; 10(5):325-32. PubMed ID: 6128281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Arginine thiazolidinecarboxylate in hepatology. Preliminary report].
    Calabrese L; Zoni R
    Minerva Dietol Gastroenterol; 1980; 26(1):51-7. PubMed ID: 7374998
    [No Abstract]   [Full Text] [Related]  

  • 19. [Value of tiadilon in hepatobiliary pathology].
    Saigot T
    Med Chir Dig; 1979; 8(6):575-6. PubMed ID: 529858
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effects of thiol compounds on experimental liver damage (II). Preventive and therapeutic effects of tiopronin (2-mercaptopropionylglycine) and glutathione on ethionine induced liver damage (author's transl)].
    Chiba T; Horiuchi M; Akashi Y
    Nihon Yakurigaku Zasshi; 1979 Sep; 75(6):551-62. PubMed ID: 540885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.